Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
89.60
-0.67 (-0.74%)
Apr 3, 2025, 1:44 PM CST

SHA:688578 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
40,62226,95518,7478,85613,59012,816
Upgrade
Market Cap Growth
43.78%43.78%111.69%-34.83%6.04%-
Upgrade
Enterprise Value
37,59323,92716,4946,91611,01512,083
Upgrade
Last Close Price
90.2759.9041.1519.4429.8328.13
Upgrade
PE Ratio
28.5718.9329.1067.85743.66-
Upgrade
Forward PE
24.7383.5983.5974.26109.82-
Upgrade
PS Ratio
11.437.589.2911.2025.6422849.52
Upgrade
PB Ratio
8.355.544.712.784.574.45
Upgrade
P/TBV Ratio
5.625.624.792.844.684.56
Upgrade
P/FCF Ratio
-30.90---
Upgrade
P/OCF Ratio
-27.7996.65463.96-
Upgrade
EV/Sales Ratio
10.576.738.178.7420.7821543.30
Upgrade
EV/EBITDA Ratio
22.5114.3328.12117.62--
Upgrade
EV/EBIT Ratio
23.0214.6530.01179.00--
Upgrade
EV/FCF Ratio
-27.18---
Upgrade
Debt / Equity Ratio
0000.000.00-
Upgrade
Debt / EBITDA Ratio
0.000.000.000.03--
Upgrade
Debt / FCF Ratio
--0.00---
Upgrade
Asset Turnover
--0.520.240.170
Upgrade
Inventory Turnover
--2.321.781.900.03
Upgrade
Quick Ratio
--7.188.6214.5923.80
Upgrade
Current Ratio
--7.468.9815.2124.58
Upgrade
Return on Equity (ROE)
32.20%32.20%17.97%4.24%0.63%-15.29%
Upgrade
Return on Assets (ROA)
--8.79%0.73%-1.43%-10.48%
Upgrade
Return on Capital (ROIC)
23.07%23.07%9.58%0.78%-1.49%-10.84%
Upgrade
Return on Capital Employed (ROCE)
--13.80%1.20%--
Upgrade
Earnings Yield
3.51%5.28%3.44%1.47%0.13%-2.42%
Upgrade
FCF Yield
-3.24%-0.59%-1.20%-2.23%
Upgrade
Dividend Yield
0.55%-0.97%---
Upgrade
Buyback Yield / Dilution
-0.04%-0.04%-0.09%1.49%-23.59%-2.30%
Upgrade
Total Shareholder Return
0.51%-0.04%0.88%1.49%-23.59%-2.30%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.